P
PHAT
Phathom Pharmaceuticals, Inc.
11.55
+0.30+2.67%Pre Market: 11.76 +0.21 +1.82%04:10 04/08 EDT
OPEN/PREV CLOSE11.16/11.25
TODAY RANGE10.96-11.64
VOL101
MARKET CAP910.13M
52 WEEK RANGE2.210-18.31
AVG VOL (3M)1.08M
% TURNOVER1.06%
TURNOVER0
P/E (TTM)-3.8066
% RANGE6.04%
EPS(TTM)-3.0342
P/E(FORWARD)-18.9344
P/B-1.8826
BVPS-6.1352
DIVIDEND--
P/S4.711
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP719.66M
SHARES OUTSTANDING78.80M
NEXT EARNINGS04/29-05/04
FREE FLOAT62.31M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
Seeking Alpha·03/27 17:41
Phathom upgraded at Barclays following pullback, Voquezna optimism
Reuters·03/27 15:48
BUZZ-U.S. STOCKS ON THE MOVE-Entergy, IDEX Corp, Quanta Services
Benzinga·03/27 13:25
This Argan Analyst Turns Bullish; Here Are Top 3 Upgrades For Friday
Reuters·03/27 13:15
BUZZ-U.S. STOCKS ON THE MOVE-Alphabet, Phathom, Argan
Dow Jones·03/27 12:43
Phathom Pharmaceuticals Price Target Raised to $18.00/Share From $16.00 by Barclays
Dow Jones·03/27 12:43
Phathom Pharmaceuticals Raised to Overweight From Equal-Weight by Barclays
Reuters·03/27 11:12
BUZZ- Barclays raises Phathom Pharmaceuticals to 'overweight'; shares rise
TipRanks·03/27 10:16
Phathom Pharmaceuticals (PHAT) was upgraded to a Buy Rating at Barclays
TipRanks·03/27 09:00
Phathom Pharmaceuticals upgraded to Overweight from Equal Weight at Barclays
Reuters·03/27 07:54
U.S. RESEARCH ROUNDUP- Brown-Forman, Chord Energy, Olaplex Holdings
TipRanks·03/23 18:25
Phathom Pharmaceuticals management to meet with Cantor
Same Industry
Name/Symbol
Change%
Price